You are here: Industry Insights > Heart failure

News List

Audit shows drop in hospital heart failure deaths pharmatimes
August 15, 2017
The latest national heart failure audit has found a significant downturn in the mortality rate among heart failure patients admitted to hospital over the past year, but says the number of ...
Heart failure market worth $16 billion by 2026 as Novartis’ drug triggers growth europeanpharmaceuticalreview
July 06, 2017
The heart failure space across the seven key markets of the US, France, Germany, Italy, Spain, the UK and Japan is set to grow to $16.1 billion by 2026…
Heart failure market worth $16 billion by 2026 as Novartis’ drug triggers growth europeanpharmaceuticalreview
July 06, 2017
The heart failure space across the seven key markets of the US, France, Germany, Italy, Spain, the UK and Japan is set to grow to $16.1 billion by 2026…
Tablet helps heart failure patients manage drug dosages europeanpharmaceuticalreview
May 25, 2017
A novel tablet is helping heart failure patients to manage their disease including drug dosages, according to new research.
ANI Launches Indapamide Tablets contractpharma
April 21, 2017
Company continues to leverage U.S.-based manufacturing assets
Novartis' serelaxin fails to meet goals of late-stage acute heart failure study firstwordpharma
March 23, 2017
Novartis announced Wednesday that a Phase III study of the experimental drug serelaxin in patients with acute heart failure (AHF) failed to meet its primary endpoints...
SGLT-2 inhibitors significantly reduce death and hospitalisations for heart failure: Astrazeneca CVD financialexpress
March 23, 2017
The study of more than 300,000 patients with type-2 diabetes showed treatment with SGLT-2 inhibitors reduced all-cause mortality by 51 per cent and risk of hospitalisation for heart failure by 39 per cent
AstraZeneca study shows SGLT-2 inhibitors significantly reduced hospitalizations for heart failure a cphi-online
March 22, 2017
Landmark real-world evidence from an international study of more than 300,000 patients with type-2 diabetes showed treatment with SGLT-2 inhibitors reduced risk of hospitalization for heart failure by 39% and all-cause mortality by 51%.
Cutting costs but not quality: heart failure hospitalisations pharmaceutical-technology
February 20, 2017
Over one million Americans are hospitalized for heart failure (HF) each year. This results in a poor prognosis for patients and places a significant financial burden on the US healthcare system.

Previous page 1 2 3 4 5 6 7 Next page